Skip to main navigation
Skip to search
Skip to main content
Charles Darwin University Home
Home
Profiles
Research Outputs
Datasets
Organisational Units
Student theses
Projects
Search by expertise, name or affiliation
Bisphosphonates for osteoporosis in people with cystic fibrosis (Review)
Louise S. Conwell,
Anne Chang
Research output
:
Contribution to journal
›
Comment/debate
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bisphosphonates for osteoporosis in people with cystic fibrosis (Review)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Confidence Interval
100%
Bisphosphonic Acid Derivative
100%
Bone Density
80%
Inpatient
60%
Cystic Fibrosis
60%
Fracture
60%
Adverse Event
40%
Bone Pain
30%
Survival
20%
Control
20%
Flu Like Syndrome
20%
Corticosteroid
20%
Transplantation
20%
Follow up
10%
Data Base
10%
Diseases
10%
Quality of Life
10%
Odds Ratio
10%
Missing Data
10%
Medline
10%
Pamidronic Acid
10%
Zoledronic Acid
10%
Osteoporosis
10%
Genetic Disorder
10%
Medicine and Dentistry
Bisphosphonate
100%
Bone Density
80%
Cystic Fibrosis
60%
Fracture
50%
Adverse Event
40%
Adult
40%
Femur
40%
Lumbar Spine
40%
Bone Pain
30%
Hip
30%
Therapeutic Procedure
20%
Survival
20%
Lung
20%
Corticosteroid
20%
Transplantation
20%
Flu Like Syndrome
20%
Follow up
10%
Diseases
10%
Genetic Disorder
10%
Odds Ratio
10%
Bone Mineralization
10%
Forearm
10%
Postmenopause
10%
Pamidronic Acid
10%
Zoledronic Acid
10%
Pharmacology, Toxicology and Pharmaceutical Science
Bisphosphonic Acid Derivative
100%
Cystic Fibrosis
60%
Fracture
60%
Adverse Event
40%
Group Trial
30%
Corticosteroid
20%
Survival
20%
Flu Like Syndrome
20%
Diseases
10%
Genetic Disorder
10%
Osteoporosis
10%
Biochemistry, Genetics and Molecular Biology
Bone Density
80%
Cystic Fibrosis
60%
Bone
30%
Survival
20%
Corticosteroid
20%
Life
10%
Data Base
10%
Genetic Disorder
10%
Reduction (Chemistry)
10%
Medline
10%
Postmenopause
10%
Bone Mineralization
10%